KalVista Pharmaceuticals (KALV) Leases: 2019-2024
Historic Leases for KalVista Pharmaceuticals (KALV) over the last 3 years, with Dec 2024 value amounting to $5.6 million.
- KalVista Pharmaceuticals' Leases was N/A to $5.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.6 million, marking a year-over-year change of. This contributed to the annual value of $6.9 million for FY2024, which is N/A change from last year.
- Per KalVista Pharmaceuticals' latest filing, its Leases stood at $5.6 million for Q4 2024, which was down 4.93% from $5.9 million recorded in Q4 2024.
- KalVista Pharmaceuticals' 5-year Leases high stood at $7.6 million for Q3 2023, and its period low was $1.3 million during Q4 2020.
- Moreover, its 2-year median value for Leases was $6.9 million (2024), whereas its average is $6.6 million.
- Its Leases has fluctuated over the past 5 years, first soared by 219.21% in 2020, then declined by 22.61% in 2024.
- Quarterly analysis of 4 years shows KalVista Pharmaceuticals' Leases stood at $1.3 million in 2020, then rose by 10.42% to $1.7 million in 2021, then reached $7.3 million in 2023, then dropped by 19.66% to $5.6 million in 2024.
- Its Leases stands at $5.6 million for Q4 2024, versus $5.9 million for Q4 2024 and $5.9 million for Q3 2024.